John & Marcia Goldman Foundation Donates to NIH Ebola Research
In the first donation of its kind for the Foundation for the National Institutes of Health (FNIH), the John & Marcia Goldman Foundation has awarded $25,000 to support Ebola research in West Africa conducted by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. The grant from the San Francisco-based foundation will support Ebola vaccine research by the NIAID Division of Clinical Research.
For more information about Ebola, including its signs and symptoms, research and statistics, please consult the following:
Centers for Disease Control: http://www.cdc.gov/vhf/ebola/index.html
To donate to the FNIH for Ebola research click here >>
Donate and Support Today
Take Action to Support Life-Saving Medical Research
Every dollar counts! Your gift to the FNIH makes our efforts possible. With your help—and in partnership with NIH—the Foundation is advancing biomedical research and training.
Donate with Confidence
For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards.
News and Highlights
Inadequate nutrition has been associated with half of deaths worldwide in children under age five. In addition, write investigators from the MAL-ED Network in a special section of the November 1 edition of Clinical Infectious Diseases, the long-term effects of “undernutrition” in young children “have been associated with cognitive and physical growth deficits across multiple generations and have been thought to suppress immunity to further infections and to reduce the efficacy of childhood vaccines. More >>
In 2015, NIH will become one of a select group of institutions of higher learning taking part in the Amgen Scholars Program. ThIs program is made possible by an $850,000 grant to the Foundation for the NIH from the Amgen Foundation. More >>
FNIH is pleased to announce a collaboration with ICON, plc to Develop a New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials.
The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. More >>